| Human |
hsa_circ_TADA2A |
- |
circRNA_102049 / hsa_circRNA_102049 |
malignant pancreatic neoplasm |
TADA2A |
miR-103a-2-5p, miR-455-3p, miR-302c-3p, miR-520d-3p, miR-302-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
- |
circRNA_102051 / hsa_circRNA_102051 |
malignant pancreatic neoplasm |
TADA2A |
miR-302c-3p, miR-520d-3p, miR-302b-3p, miR-302d-3p, miR-197-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
- |
breast cancer |
TADA2A |
miR-203a-3p, miR-302c-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
- |
breast cancer |
TADA2A |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
- |
osteosarcoma |
TADA2A |
miR-203a-3p |
Q
H
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
circ-TADA2A |
pancreatic adenocarcinoma |
TADA2A |
hsa-miR-214 |
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
- |
breast cancer |
TADA2A |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
- |
breast cancer |
TADA2A |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
- |
pancreatic ductal adenocarcinoma |
TADA2A |
hsa-mir-1, hsa-mir-214, hsa-mir-224, hsa-mir-223, hsa-mir-1305, hsa-mir-375 |
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
- |
pancreatic ductal adenocarcinoma |
TADA2A |
hsa-mir-1, hsa-mir-214, hsa-mir-224, hsa-mir-223, hsa-mir-1305, hsa-mir-375 |
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
- |
circTADA2A |
colorectal cancer |
TADA2A |
miR-374a-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
hsa_circ_102049 |
colorectal cancer |
TADA2A |
miR-761, miR-192-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
hsa_circRNA_0043278 |
glioblastoma |
TADA2A |
miR-638 |
Q
| UP |
More |
| Human |
hsa_circ_TADA2A |
- |
circTADA2A |
osteosarcoma |
TADA2A |
miR-129-5p |
Q
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
circRNA_102049 |
pancreatic ductal adenocarcinoma |
TADA2A |
miR-455-3p / hsa-miR-455-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
hsa_circTADA2A_011 |
colorectal cancer |
TADA2A |
miR-192-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
circTADA2A |
non-small cell lung carcinoma |
TADA2A |
miR-638 |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
- |
circTADA2A |
colorectal cancer |
TADA2A |
miR-1229 |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
- |
triple-negative breast carcinoma |
TADA2A |
miR-197-5p |
Q
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043280 |
- |
cervical cancer |
TADA2A |
miR-203a-3p |
Q
H
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
- |
breast cancer |
TADA2A |
miR-455-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0106714 |
Circ0106714 |
colorectal cancer |
TADA2A |
miR-942-5p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
Circ_0006220 |
prostate cancer |
TADA2A |
miR-520f-3p |
Q
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
circTADA2A |
acute erythroid leukemia |
TADA2A |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
circTADA2A |
acute myeloid leukemia |
TADA2A |
miR-638 |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
hsa_circRNA_102049 |
colorectal cancer |
TADA2A |
miR-455-3p |
Q
| UP |
More |
| Human |
hsa_circ_TADA2A |
- |
circTADA2A |
non-small cell lung carcinoma |
TADA2A |
miR-450b-3p |
Q
| UP |
More |
| Human |
hsa_circ_TADA2A |
- |
hsa_circRNA_102049 / circRNA_102049 |
Alzheimer disease |
TADA2A |
hsa-miR-197-5p, hsa-miR-6871-5p, hsa-miR-6751-5p, hsa-miR-6803-5p, hsa-miR-194-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
circ_0006220 |
non-small cell lung carcinoma |
TADA2A |
miR-342-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
circTADA2A |
colorectal cancer |
TADA2A |
- |
Q
| UP |
More |
| Human |
hsa_circ_TADA2A |
- |
hsa_circRNA_102051 / hsa_circ_102051 |
colorectal cancer |
TADA2A |
miR-203a |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
- |
hepatocellular carcinoma |
TADA2A |
miR-221-3p, miR-222-3p |
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
circTADA2A |
melanoma |
TADA2A |
- |
Q
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043273 |
- |
lung adenocarcinoma |
TADA2A |
miR-520f, miR-455-3p, miR-129-5p, miR-374a-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
circ_0043278 / hsa_102049 |
non-small cell lung carcinoma |
TADA2A |
miR-520f, miR-1299, miR-203, miR-450b-3p, miR-526b |
Q
M
| UP |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043280 |
- |
cervical squamous cell carcinoma |
TADA2A |
hsa-miR-638 |
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0043278 |
- |
breast cancer |
TADA2A |
miR-103a-2-5p, miR-302b-3p, miR-302c-3p, miR-455-3p, miR-520d-3p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
hsa_circ_0006220 |
- |
breast cancer |
TADA2A |
miR-197-5p |
Q
M
| DN |
More |
| Human |
hsa_circ_TADA2A |
- |
CircTADA2A / hsa_circRNA_102051 |
non-small cell lung carcinoma |
TADA2A |
miR-214-3p |
Q
M
| UP |
More |